Yf-Vax Global Market Report 2025

Yf-Vax Global Market Report 2025 ) – By Vaccine Type (Live Attenuated Vaccines, Fractional Dose Vaccine), By Transmission Type (Sylvatic Yellow Fever, Intermediate Yellow Fever, Urban Yellow Fever), By Distribution Channel (Hospitals, Retail Pharmacies, Government Health Programs), By End User (Adult, Geriatric, Pediatric) – Market Size, Trends, And Global Forecast 2025-2034

Name: Yf-Vax Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Yf-Vax Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Yf-Vax Market Definition

YF-Vax is a live-attenuated vaccine designed to provide long-lasting protection against yellow fever, a potentially severe viral disease spread by infected mosquitoes, and is commonly recommended for travelers and residents in endemic areas.

The main types of Yf-Vax are live attenuated vaccines, fractional dose vaccines. Live attenuated vaccines are a type of vaccine that contains live, but weakened, forms of the virus or bacteria that cause the disease. The various transmission types include sylvatic yellow fever, intermediate yellow fever, urban yellow fever. These are distributed through various distribution channels such as hospitals, retail pharmacies, government health programs and are used by various end users such as adult, geriatric, pediatric

Yf-Vax Market Segmentation

The Yf-Vaxmarket covered in this report is segmented –

1) By Vaccine Type: Live Attenuated Vaccines, Fractional Dose Vaccine

2) By Transmission Type: Sylvatic Yellow Fever, Intermediate Yellow Fever, Urban Yellow Fever

3) By Distribution Channel: Hospitals, Retail Pharmacies, Government Health Programs

4) By End User: Adult, Geriatric, Pediatric

Yf-Vax Market Size and growth rate 2025 to 2029: Graph

Yf-Vax Market Size 2025 And Growth Rate

The Yf-Vax market size has grown strongly in recent years. It will grow from $6,280 million in 2024 to $6,780 million in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing global travel to yellow fever-endemic regions and rising awareness of yellow fever prevention, growing understanding of the importance of immunization in preventing yellow fever transmission.

Yf-Vax Market Growth Forecast

The Yf-Vax market size is expected to see strong growth in the next few years. It will grow to $9,120 million in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growing demand for vaccination in emerging economies and advancements in vaccine distribution channels, government-sponsored vaccination programs, ongoing advancements in vaccine distribution infrastructure, and improvements in vaccine formulations and availability. Major trends in the forecast period include product approvals, partnerships and developments in yellow vaccine.

Book your 30 minutes free consultation with our research experts

Yf-Vax Market Driver: Rising Awareness of Vector-Borne Diseases Fuels Growth in YF-Vax Market

The increasing awareness of vector-borne diseases is expected to propel the growth of the YF-Vax market going forward. Vector-borne diseases are infectious diseases transmitted to humans and animals through the bite of infected arthropods, such as mosquitoes, ticks, and fleas, carrying pathogens such as viruses, bacteria, or parasites, leading to illnesses such as malaria, dengue, and Lyme disease. The rise in the prevalence of vector-borne diseases (VBDs) is due to climate change, urbanization, increased global travel, and expanding mosquito populations, leading to more outbreaks being reported. YF-Vax effectively prevents yellow fever, a vector-borne disease, by stimulating the immune system to produce antibodies, providing long-lasting protection against the virus transmitted by infected mosquitoes. For instance, in March 2024, according to the World Organization for Animal Health, a France-based intergovernmental organization, from 2023 to March 2024, vector-borne diseases caused 2,422 outbreaks in 28 countries, with Europe reporting 697 outbreaks. Therefore, increasing awareness of vector-borne diseases is driving growth in the YF-Vax market.

Yf-Vax Market Driver: Impact Of Rising Healthcare Spending On The Yf-Vax Market

The rise in healthcare spending is expected to propel the growth of the Yf-Vax market going forward. Healthcare spending is attributed to aging population, advancements in medical technology, rising prevalence of chronic diseases, and increased demand for healthcare services. YF-VAX, by providing effective yellow fever prevention, helps reduce healthcare expenditure by minimizing the costs associated with treating severe infections, hospitalizations, and outbreak management. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, rise in healthcare spending is driving the growth of the Yf-Vax market.

Global Yf-Vax Market Major Players

Major companies operating in the yf-vax market include Sanofi S.A.

Global Yf-Vax Market Trend: Enhancing Vaccine Manufacturing Capacity Through Collaboration

The key trend in the Yf-Vax market is adopting a strategic partnership approach to enhance technology integration and expand market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in March 2022, The International Finance Corporation (IFC), a US-based financial services company, partnered with Institut Pasteur de Dakar (IPD), a Senegal-based vaccine manufacturer specializing in yellow fever vaccines, to establish a vaccine manufacturing facility in Senegal. The $222 million project will be funded through a combination of public, private, and grant financing. This new plant will significantly enhance IPD's vaccine production capacity, which has traditionally focused on yellow fever. Initially, it will produce COVID-19 vaccines, with plans to expand to other vaccines in the future. At full capacity, the facility aims to produce up to 300 million doses annually for Africa.

Regional Outlook For The Global Yf-Vax Market

North America was the largest region in the yf-vax market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yf-vax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the yf-vax market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Yf-Vax Market?

The yf-vax market consists of sales of vaccine syringes, pre-filled injection devices, and immunization kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Yf-Vax Industry?

The Yf-Vax market research report is one of a series of new reports from The Business Research Company that provides Yf-Vax market statistics, including Yf-Vax industry global market size, regional shares, competitors with a Yf-Vax market share, detailed Yf-Vax market segments, market trends, and opportunities, and any further data you may need to thrive in the Yf-Vax industry. This Yf-Vax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Yf-Vax Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of 7.7% from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Vaccine Type: Live Attenuated Vaccines, Fractional Dose Vaccine 2) By Transmission Type: Sylvatic Yellow Fever, Intermediate Yellow Fever, Urban Yellow Fever 3) By Distribution Channel: Hospitals, Retail Pharmacies, Government Health Programs 4) By End User: Adult, Geriatric, Pediatric
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	Sanofi S.A.
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Yf-Vax Market Characteristics

3. Yf-Vax Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Yf-Vax Market Trends And Strategies

5. Yf-Vax Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Yf-Vax Growth Analysis And Strategic Analysis Framework

6.1. Global Yf-Vax PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Yf-Vax Market Growth Rate Analysis

6.4. Global Yf-Vax Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Yf-Vax Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Yf-Vax Total Addressable Market (TAM)

7. Global Yf-Vax Market Pricing Analysis & Forecasts

8. Yf-Vax Market Segmentation

8.1. Global Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Live Attenuated Vaccines

Fractional Dose Vaccines

8.2. Global Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sylvatic Yellow Fever

Intermediate Yellow Fever

Urban Yellow Fever

8.3. Global Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Retail Pharmacies

Government Health Programs

8.4. Global Yf-Vax Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adult

Geriatric

Pediatric

9. Global Yf-Vax Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Yf-Vax Market Regional And Country Analysis

10.1. Global Yf-Vax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Yf-Vax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Yf-Vax Market

11.1. Asia-Pacific Yf-Vax Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Yf-Vax Market

12.1. China Yf-Vax Market Overview

12.2. China Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Yf-Vax Market

13.1. India Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Yf-Vax Market

14.1. Japan Yf-Vax Market Overview

14.2. Japan Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Yf-Vax Market

15.1. Australia Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Yf-Vax Market

16.1. South Korea Yf-Vax Market Overview

16.2. South Korea Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Yf-Vax Market

17.1. Western Europe Yf-Vax Market Overview

17.2. Western Europe Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Yf-Vax Market

18.1. UK Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Yf-Vax Market

19.1. Germany Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Yf-Vax Market

20.1. France Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Yf-Vax Market

21.1. Eastern Europe Yf-Vax Market Overview

21.2. Eastern Europe Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Yf-Vax Market

22.1. North America Yf-Vax Market Overview

22.2. North America Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Yf-Vax Market

23.1. USA Yf-Vax Market Overview

23.2. USA Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Yf-Vax Market

24.1. Canada Yf-Vax Market Overview

24.2. Canada Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Yf-Vax Market

25.1. South America Yf-Vax Market Overview

25.2. South America Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Yf-Vax Market

26.1. Middle East Yf-Vax Market Overview

26.2. Middle East Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Yf-Vax Market

27.1. Africa Yf-Vax Market Overview

27.2. Africa Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Yf-Vax Market Competitive Landscape And Company Profiles

28.1. Yf-Vax Market Competitive Landscape

28.2. Yf-Vax Market Company Profiles

28.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

29. Global Yf-Vax Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Yf-Vax Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Yf-Vax Market

32. Recent Developments In The Yf-Vax Market

33. Yf-Vax Market High Potential Countries, Segments and Strategies

33.1 Yf-Vax Market In 2029 - Countries Offering Most New Opportunities

33.2 Yf-Vax Market In 2029 - Segments Offering Most New Opportunities

33.3 Yf-Vax Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Yf-Vax Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Yf-Vax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Yf-Vax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: India, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Japan, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Australia, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: South Korea, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: South Korea, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Western Europe, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Western Europe, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: UK, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: UK, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Germany, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Germany, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: France, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: France, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Eastern Europe, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Eastern Europe, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: North America, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: North America, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: USA, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: USA, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Canada, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Canada, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: South America, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: South America, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Middle East, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Middle East, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Africa, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Africa, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Sanofi S.A. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Yf-Vax Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Yf-Vax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Yf-Vax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: India, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Japan, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Australia, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: South Korea, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: South Korea, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Western Europe, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Western Europe, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: UK, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: UK, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Germany, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Germany, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: France, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: France, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Eastern Europe, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Eastern Europe, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: North America, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: North America, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: USA, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: USA, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Canada, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Canada, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: South America, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: South America, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Middle East, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Middle East, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Africa, Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Africa, Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Sanofi S.A. Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the pancreatic cancer drugs market research report 2022 with industry size, share, segments and market growth

Patient Temperature Monitoring Global Market Report 2025 – By Type( Contact-based Temperature Monitoring Systems, Non-Contact-based Temperature Monitoring System), By Site( Non Invasive Temperature Monitoring, Invasive Temperature Monitoring), By Application( Pyrexia/Fever, Hypothermia, Blood Transfusion, Anesthesia, Other Applications), By End User( Hospital and Surgical Centers, Nursing Facilities, Ambulatory Care Centers, Home Care, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cold Chain Temperature Monitoring Global Market Report 2025 – By Hardware (Conventional Temperature Loggers, Real Time Monitoring Devices, Resistance Temperature Detectors, Temperature Indicators, Other Hardware), By Software (On Premise, Cloud Based), By End User (Fish, Meat And Seafood, Processed Food, Pharmaceuticals, Bakery And Confectionaries, Fruits And Vegetables, Dairy Products, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

In-Vitro Transcription Templates Global Market Report 2025 – By Treatment (Vaccine, Therapeutic), By Research Stage ( Exploratory, Clinical), By Disease (Cancer, Infectious Disease, Lifestyle Disease, Genetic Disease, Other Diseases), By End User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academics And Research, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tetanus Toxoid Vaccine Global Market Report 2025 – By Vaccine Type (Tetanus Toxoid (TT), Diphtheria And Tetanus (DT), Tetanus And Diphtheria (Td), Diphtheria, Tetanus, And Pertussis (Dtap), Tetanus, Diphtheria, And Pertussis (Tdap), Pentavalent, Hexavalent, Other Types), By Age Group (Pediatric, Adult), By End-User (Hospitals And Clinics, Government Organizations, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Yellow Fever Vaccine Global Market Report 2025 – By Product (Powder, Liquid), By Treatment Type (Pain Management Drugs, Oral Rehydration), By Application (Routine Immunization, Travelers, Other Applications), By End-User (Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Multivalent Vaccines Global Market Report 2025 – By Type (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines), By Disease (Influenza, Pneumonia, Hepatitis, Meningitis, Rotavirus), By Route Of Administration (Oral, Injectable), By Age Group (Pediatrics, Adults, Geriatrics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cervical Cancer Vaccine Global Market Report 2025 – By Type (Cervarix, Gardasil, Gardasil 9), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-Users (Hospital, Biotechnology Company, Academic And Research Organizations, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Human Papillomavirus (HPV) Vaccine Global Market Report 2025 – By Type (Tetravalent, Nonavalent, Bivalent), By Disease Indication (Cervical Cancer, Anal Cancer, Vulvar And Vaginal Cancer, Penile Cancer, Oropharyngeal Cancer, Other Indications), By Distribution Channel (Hospital And Retail Pharmacies, Government Suppliers, Other Channels), By Industry Vertical (Public And Private Alliance, Government Entities, Physicians, Other Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Yf-Vax market?

How will the Yf-Vax market drivers and restraints affect the market dynamics? What forces will shape the Yf-Vax industry going forward?

The Yf-Vax market major growth driver - Rising Awareness of Vector-Borne Diseases Fuels Growth in YF-Vax Market. For further insights on the Yf-Vax market, request a sample here

What is the forecast market size or the forecast market value of the Yf-Vax market?

The Yf-Vax market size has grown strongly in recent years. The Yf-Vax market size has grown strongly in recent years. It will grow from $6,280 million in 2024 to $6,780 million in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing global travel to yellow fever-endemic regions and rising awareness of yellow fever prevention, growing understanding of the importance of immunization in preventing yellow fever transmission. The Yf-Vax market size is expected to see strong growth in the next few years. It will grow to $9,120 million in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growing demand for vaccination in emerging economies and advancements in vaccine distribution channels, government-sponsored vaccination programs, ongoing advancements in vaccine distribution infrastructure, and improvements in vaccine formulations and availability. Major trends in the forecast period include product approvals, partnerships and developments in yellow vaccine. For further insights on the Yf-Vax market, request a sample here

How is the Yf-Vax market segmented?

The yf-vaxmarket covered in this report is segmented –
1) By Vaccine Type: Live Attenuated Vaccines; Fractional Dose Vaccine
2) By Transmission Type: Sylvatic Yellow Fever; Intermediate Yellow Fever; Urban Yellow Fever
3) By Distribution Channel: Hospitals; Retail Pharmacies; Government Health Programs
4) By End User: Adult; Geriatric; Pediatric For further insights on the Yf-Vax market, request a sample here

Which region has the largest share of the Yf-Vax market? What are the other regions covered in the report?

Who are the major players in the Yf-Vax market?

Major companies operating in the yf-vax market include Sanofi S.A. . For further insights on the Yf-Vax market, request a sample here.

What are the key trends in the Yf-Vax market?

Major trends in the Yf-Vax market include Enhancing Vaccine Manufacturing Capacity Through Collaboration. For further insights on the Yf-Vax market, request a sample here.

What are the major opportunities in the Yf-Vax market? What are the strategies for the Yf-Vax market?

For detailed insights on the major opportunities and strategies in the Yf-Vax market, request a sample here.

How does the Yf-Vax market relate to the overall economy and other similar markets?

For detailed insights on Yf-Vax's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Yf-Vax industry?

For detailed insights on the mergers and acquisitions in the Yf-Vax industry, request a sample here.

What are the key dynamics influencing the Yf-Vax market growth? SWOT analysis of the Yf-Vax market.

For detailed insights on the key dynamics influencing the Yf-Vax market growth and SWOT analysis of the Yf-Vax industry, request a sample here.